abstract Huntington's disease (HD) is a progressive neurodegenerative disorder associated with selective neuronal cell death. Abnormal aggregation of huntingtin protein with polyQ expansion has been shown to be causally linked to HD. Grape seed polyphenolic extract (GSPE) is a natural compound that has previously been shown to interfere with aggregations of proteins involved in neurological disorders, such as amyloid beta peptides (Aβ) and Tau protein. In this study we found that GSPE treatment significantly inhibits polyQ aggregation in phaeochromocytoma (PC)-12 cell line containing an ecdysone-inducible protein comprising the first 17 amino acid of huntingtin plus 103 glutamines fused with enhanced GFP. In vivo feasibility studies using the Q93httexon1 drosophila model of HD, we extended our in vitro evidence and found that flies fed with GSPE had a significantly improved lifespan compared to the control flies. Using the R6/2 rodent model of HD, we found that oral administration of 100 mg/kg/day GSPE (equivalent to 500mg per day in human) significantly attenuated the motor skill decay as well as extended the lifespan in the R6/2 mice relative to vehicle-control mice. Collectively, our studies strongly suggest that GSPE might be able to modulate the onset and/or progression of HD.
introduction
Huntington's disease (HD) is an autosomaldominant neurological disorder that is caused by an unstable trinucleotide CAG repeat expansion at the N-terminus of the IT-15 gene, encoding the ~350 kDa huntingtin protein (htt) [1] . The mutation leads to production of htt proteins with an abnormal length of polyglutamine (polyQ) repeats. It is hypothesized that the polyQ repeats causes a gain of function resulting in abnormal protein-protein interaction [2, 3] .
HD is estimated to affect five to seven people in 100,000 throughout the world [4] . Clinical manifestation of the disease is characterized by severe cognitive and personality changes [5] [6] [7] , accompanied by coordination decline and motor deficits that eventually lead to immobility [8] . Currently, there is no cure for this devastating neurodegenerative disorder, and treatments are mainly focused on alleviating cognitive and psychological symptoms. Recent evidence indicates that mutant htt (mhtt) aggregation in susceptible brain cells may be responsible for the onset and progression of HD phenotypes, and that the pathology and death of affected neurons are associated with the accumulation of mutant proteins in insoluble aggregates [9] [10] [11] [12] . There are still debates regarding the role of aggregation in disease pathogenesis and several studies showed that the formation of aggregation could be a protective/defensive mechanism [10, 13, 14] .
However, therapeutic strategies targeting polyQ aggregation have demonstrated some efficacy in various models of HD [15] [16] [17] [18] , suggesting that inhibition of abnormal neuronal htt protein aggregation might be a novel approach for HD treatment.
We previously reported that treatment with a select grape seed polyphenolic extract (GSPE) significantly attenuates spatial memory impairment in a mouse model of AD phenotypes [19] . Using both physical and biochemical methodologies, we found that GSPE can directly interfere with abnormal aggregation of proteins involved in neurological disorders, such as Aβ petides [19, 20] and Tau proteins [21] . GSPE is also a strong antioxidant and powerful metal chelator that can effectively reduce reactive oxygen species in vivo. Previous studies have demonstrated increased oxidative damage in post-mortem brains of HD patients [22, 23] , and increased free radical production in animal models of HD [24] , indicating the involvement of oxidative stress in HD pathogenesis. Based on these findings, in the present study we explore the role of GSPE in HD-type conditions. We report for the first time that GSPE treatment could significantly extend lifespan in the glutamines fused with enhanced GFP [17] were used for the in vitro cell based study. 
experiment Procedures

statistical analyses
2-tailed student t-tests were used for analyzing rotarod tests. For surviving studies in drosophila subjects, the results of the four mortality analyses on drosophila survival were compared by a chi-square test for the differences among the respective z statistics that were obtained as square roots of the respective chi-squares on 1 degree of freedom from the Kaplan-Maier analyses. For surviving studies in mice, the log-rank test was used. Figure 2A ). In control studies in wild type mice, we found that GSPE treatment had no effect on motor function (data not shown).
results
GSPE treatment extends lifespan
In addition, we found that GSPE treatment significantly extended lifespan in R6/2 mice compared with water-treated control mice ( Figure 2B , Log-rank test, p= 0.0220).
The median lifespan for non-treated control R6/2 mice was 90.5 days, while GSPE treated mice had a median lifespan of 98 days.
GSPE treatment reduces protein aggregation in PC-12 htt103Q-EGFP cells
Given the anti-protein aggregation role of GSPE in other neurological disorders [19] [20] [21] , and our finding that GSPE could significant reduce motor deficits and increase lifespan in two independent in vivo HD models, we next tested whether GSPE exerts its beneficial effect by interfering with the formation of polyQ-containing aggregates. were assessed using accelerating rotarod at 6 weeks, 9 weeks and 11 weeks. The average of three trials conducted for each test was recorded. Duration on the rotarod is defined as latency time taken the animals to fall off the apparatus. (B) R6/2 transgenic mice were treated either with 100 mg/kg/day GSPE or H 2 O (as control group) and the survival rate was recorded daily. 
Discussion
HD is a devastating neurological disease caused by abnormal trinucleotide CAG repeats.
It is associated with neuronal intranuclear inclusions (NIIs) as well as cytoplasmic inclusions containing truncated polyQ fragments [2, 30] , resulting in progressive neuronal loss in the caudate and putamen [31] .
Currently there is no cure. [14] Saudou F, Finkbeiner S, Devys D, Greenberg ME. A unique feature of GSPE is that it is readily absorbed through the intestinal mucosa due to the modification of the constituent polyphenols [37] . Moreover, GSPE is well-tolerated in both humans and rodents [38] . One of the main obstacles for applying polyphenolic compound in the treatment of neurological disorders is the limited understanding of their bioactivity and whether they can pass the blood brain barrier and reach the central nervous system. In a recent bioavailability studies, we showed that GSPE and its metabolites can be detected in the brain when delivered at doses in the equivalent range of that employed in our feasibility studies using the R6/2 mouse model of HD [39] . 
